Home › Funds › Giverny Capital Inc. › RMD
Giverny Capital Inc. position in RMD
RESMED INC · Health Care
Giverny Capital Inc. reported holding 369,970 shares of RMD (RESMED INC) in its Q3 2026 13F filing — a position valued at US$81.8M, representing 2.80% of its reported portfolio and ranking #12 among its reported holdings. Giverny Capital Inc. has disclosed RMD holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Giverny Capital Inc.'s RMD position evolved
Giverny Capital Inc. first disclosed a stake in RMD in Q3 2025 at 235,418 shares (US$64.4M). The position peaked in Q3 2026 at 369,970 shares, worth US$81.8M. Across 5 filings, Giverny Capital Inc. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 369,970 shares valued at US$81.8M — a reduction of -17,695 shares quarter over quarter.. Notable position changes include a 69% increase in Q2 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 235.42K | $64.44M | New |
| Q4 2025 | 235.39K | $56.70M | Hold |
| Q1 2026 | 230.00K | $51.63M | Reduce |
| Q2 2026 | 387.67K | $75.55M | Add |
| Q3 2026 | 369.97K | $81.80M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RMD and 13F data
RMD (RESMED INC) is a Health Care company. 31 other funds we track also report a position in RMD — the largest reported positions include Ilex Capital Partners (UK) LLP (US$163.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RMD
- Ilex Capital Partners (UK) LLP 737.47K sh · $163.06M · Q3 2026
More on Giverny Capital Inc.
FAQ
How long has Giverny Capital Inc. held RMD?
Giverny Capital Inc. has disclosed RMD holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Giverny Capital Inc.'s current position in RMD?
As of Q3 2026, Giverny Capital Inc. holds 369.97K shares of RMD (RESMED INC), valued at $81.80M, representing 2.80% of its reported portfolio and ranking #12.
Has Giverny Capital Inc. been buying or selling RMD?
In the latest 13F filing (Q3 2026), Giverny Capital Inc. reduced its position in RMD. The position peaked in Q3 2026 at 369.97K shares.
Which other funds hold RMD?
Other major institutional holders of RMD include Ilex Capital Partners (UK) LLP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.